158 related articles for article (PubMed ID: 25065357)
1. Protease-activated receptor 2 suppresses lymphangiogenesis and subsequent lymph node metastasis in a murine pancreatic cancer model.
Shi K; Queiroz KC; Roelofs JJ; van Noesel CJ; Richel DJ; Spek CA
J Pathol; 2014 Nov; 234(3):398-409. PubMed ID: 25065357
[TBL] [Abstract][Full Text] [Related]
2. Re: Shi et al. Protease-activated receptor 2 suppresses lymphangiogenesis and subsequent lymph node metastasis in a murine pancreatic cancer model. J Pathol 2014;234: 398-409.
Rohan Z; Olejar T; Matej R
J Pathol; 2015 May; 236(1):128-9. PubMed ID: 25488199
[No Abstract] [Full Text] [Related]
3. Authors' reply-Re: Shi et al. Protease-activated receptor 2 suppresses lymphangiogenesis and subsequent lymph node metastasis in a murine pancreatic cancer model. J Pathol 2014;234: 398-409.
Shi K; Spek CA
J Pathol; 2015 May; 236(1):130. PubMed ID: 25504568
[No Abstract] [Full Text] [Related]
4. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
5. Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis.
Sipos B; Kojima M; Tiemann K; Klapper W; Kruse ML; Kalthoff H; Schniewind B; Tepel J; Weich H; Kerjaschki D; Klöppel G
J Pathol; 2005 Nov; 207(3):301-12. PubMed ID: 16161179
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis.
Ochi N; Matsuo Y; Sawai H; Yasuda A; Takahashi H; Sato M; Funahashi H; Okada Y; Manabe T
Pancreas; 2007 May; 34(4):444-51. PubMed ID: 17446844
[TBL] [Abstract][Full Text] [Related]
7. Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread.
Schneider M; Büchler P; Giese N; Giese T; Wilting J; Büchler MW; Friess H
Int J Oncol; 2006 Apr; 28(4):883-90. PubMed ID: 16525637
[TBL] [Abstract][Full Text] [Related]
8. Loss of neural cell adhesion molecule induces tumor metastasis by up-regulating lymphangiogenesis.
Crnic I; Strittmatter K; Cavallaro U; Kopfstein L; Jussila L; Alitalo K; Christofori G
Cancer Res; 2004 Dec; 64(23):8630-8. PubMed ID: 15574770
[TBL] [Abstract][Full Text] [Related]
9. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
[TBL] [Abstract][Full Text] [Related]
10. Lymphangiogenesis and tumour metastasis.
Tille JC; Nisato R; Pepper MS
Novartis Found Symp; 2004; 256():112-31; discussion 132-6, 259-69. PubMed ID: 15027486
[TBL] [Abstract][Full Text] [Related]
11. VEGF-D deficiency in mice does not affect embryonic or postnatal lymphangiogenesis but reduces lymphatic metastasis.
Koch M; Dettori D; Van Nuffelen A; Souffreau J; Marconcini L; Wallays G; Moons L; Bruyère F; Oliviero S; Noel A; Foidart JM; Carmeliet P; Dewerchin M
J Pathol; 2009 Nov; 219(3):356-64. PubMed ID: 19718705
[TBL] [Abstract][Full Text] [Related]
12. Paralemmin-1 is expressed in lymphatic endothelial cells and modulates cell migration, cell maturation and tumor lymphangiogenesis.
Albrecht I; Bieri R; Leu A; Granacher P; Hagmann J; Kilimann MW; Christofori G
Angiogenesis; 2013 Oct; 16(4):795-807. PubMed ID: 23709172
[TBL] [Abstract][Full Text] [Related]
13. [Expression of vascular endothelial growth factor C in pancreatic cancer and its effect upon lymph node metastasis].
Li K; Li MJ; He T; Zheng Z; Zheng XL; Qu BH; Wang Y; Duan X; Zheng YJ
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2386-90. PubMed ID: 20137690
[TBL] [Abstract][Full Text] [Related]
14. A role for protease-activated receptor-2 in pancreatic cancer cell proliferation.
Shimamoto R; Sawada T; Uchima Y; Inoue M; Kimura K; Yamashita Y; Yamada N; Nishihara T; Ohira M; Hirakawa K
Int J Oncol; 2004 Jun; 24(6):1401-6. PubMed ID: 15138580
[TBL] [Abstract][Full Text] [Related]
15. Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer.
Van den Eynden GG; Van der Auwera I; Van Laere SJ; Trinh XB; Colpaert CG; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
J Pathol; 2007 Sep; 213(1):56-64. PubMed ID: 17674348
[TBL] [Abstract][Full Text] [Related]
16. Protease-activated receptor-2 regulates cell proliferation and enhances cyclooxygenase-2 mRNA expression in human pancreatic cancer cells.
Yada K; Shibata K; Matsumoto T; Ohta M; Yokoyama S; Kitano S
J Surg Oncol; 2005 Feb; 89(2):79-85. PubMed ID: 15660373
[TBL] [Abstract][Full Text] [Related]
17. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
18. c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation.
Chang TM; Chu PY; Hung WC; Shan YS; Lin HY; Huang KW; Chang JS; Chen LT; Tsai HJ
Cancer Sci; 2021 Jan; 112(1):243-253. PubMed ID: 33128283
[TBL] [Abstract][Full Text] [Related]
19. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer.
Van den Eynden GG; Van der Auwera I; Van Laere SJ; Colpaert CG; Turley H; Harris AL; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
Br J Cancer; 2005 Nov; 93(10):1128-36. PubMed ID: 16251878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
